vimarsana.com
  1. Home
  2. Live Updates
  3. First In Class Selective Regulatoryt Cell - Breaking News

First In Class Selective Regulatoryt Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NEKTAR THERAPEUTICS : Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 1.02 Termination of Material Definitive Agreement. On April 27, 2023, Nektar Therapeutics, a Delaware corporation , issued a press release announcing it will regain full rights to. | April 27, 2023

United statesEli lillyNektar therapeuticsSelective regulatory treg therapy in clinical developmentSecurities exchangeCompany lillyMaterial definitiveLicense agreementQuarterly reportCurrent reportSecurities exchange actSecurities actExchange actTherapeutics announces it will regainFull rightsFirst in class selective regulatoryt cell

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.